News
3h
Zacks Investment Research on MSNElite Pharmaceuticals Stock Dips Despite Record FY25 Revenue JumpShares of Elite Pharmaceuticals, Inc. ELTP have lost 15.7% since the company reported its earnings for the fiscal year ended ...
MPs will have the opportunity to debate a ban on fossil fuel advertising and sponsorship and to address its impact on climate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results